Navigation Links
Costly breast cancer screenings don't add up to better outcomes
Date:1/7/2013

Even though Medicare spends over $1 billion per year on breast cancer screenings such as a mammography, there is no evidence that higher spending benefits older women, researchers at Yale School of Medicine found in a study published Online First by JAMA Internal Medicine, a JAMA Network publication.

Led by Cary Gross, M.D., associate professor of internal medicine at Yale School of Medicine and director of the Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, the study sought to provide a comprehensive understanding of breast cancer expenditures that incorporate the cost of screening and associated work-up, as well as treatment. They assessed overall national costs, as well as variation in costs across geographic regions.

The Yale COPPER team calculated Medicare expenditures for breast cancer screening and treatment in 137,274 female Medicare beneficiaries who had not had breast cancer before 2006, and followed them for two years to observe screening, breast cancer incidence, and associated cost.

The team found substantial variation across geographic regions in Medicare spending for breast cancer screening ranging from $40 to $110 per female Medicare beneficiary. The majority of the difference in costs was due to the use of newer, more expensive screening technologies in the higher-cost areas.

"Although screening costs varied more than two-fold across geographic regions, there was no evidence that higher expenditures were benefiting women living in the high-cost regions," said Gross, who is a member of Yale Cancer Center. "Specifically, there was no relation between screening expenditures and the detection of advanced cancers."

Recent guidelines from the United States Preventive Services Task Force have concluded that there is insufficient evidence regarding the effectiveness of breast cancer screening for women age 75 years and older. The COPPER team found that over $400 million is being spent annually on screening Medicare beneficiaries in this age group.

"We need further studies to identify which women will benefit from screening, and how to screen effectively and efficiently," said Gross. "In some instances, breast cancer screening can save lives. But no woman wants to undergo testing if it is likely to cause more harm than good, and no health system particularly ours can afford to spend hundreds of millions of dollars on screening programs without evidence to support them."


'/>"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Source:Eurekalert

Related medicine news :

1. Availability of Beds, Poverty Drive Costly Hospital Readmissions
2. New process would make anti-malarial drug less costly
3. ASBMR task force urges use of fracture liaision services to reduce costly osteoporosis bone breaks
4. Less-experienced physicians more costly than more-experienced physicians
5. Policy considerations pose options for leaders to reduce costly disparities in diabetes
6. Costly, Repeat Medical Testing Common for Medicare Patients: Study
7. Communications training, surgical checklist can reduce costly postoperative complications
8. Despite hype, costly prostate cancer treatment offers little relief from side effects
9. Costly Breast Cancer Screenings May Not Help Seniors: Study
10. Eliminating the good cholesterol receptor may fight breast cancer
11. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Florida (PRWEB) , ... February 09, 2016 , ... ... cold therapy products, announced today the introduction of the newly designed, innovative shoulder ... comfort and better cold therapy coverage for the injured arm and shoulder to ...
(Date:2/9/2016)... ... February 09, 2016 , ... Sir Grout, the leading ... proud to announce that many of their franchises have received the Super Service ... surface restoration franchises received customer recognition through positive reviews and testimonials, as well ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Brain ... won. A team from 21st Century Medicine (21CM) ( http://www.21cm.com/ ), spearheaded ... delicate neural circuits of an intact rabbit brain for extremely long-term storage using ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... with BASF Human Nutrition into the Food & Beverage and ... been BASF’s channel partner throughout Canada and USA geographies east of the Rocky ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Valentine’s Season is famous for gift giving with flowers, chocolates ... they are loved. This year, for more than 5.6 million Americans suffering with Alzheimer’s, ... be enough to remind them of the lives they’ve led and the people they’ve touched. ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... LONDON , Feb.8, 2016 Aesthetic Devices ... GlobalData,s Medical Devices sector report, "Aesthetic Devices - Medical ... Devices currently in pipeline stage. This ... secondary and primary research by GlobalData,s team of industry ... be removed or altered based on the availability and ...
(Date:2/8/2016)... 8, 2016  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... fourth quarter and year-end 2015 results after the Nasdaq ... then host a live conference call and webcast to ... Thursday afternoon, February 11, 2016 at 4:30 p.m. Eastern ... --> http://www.neurocrine.com . --> Participants ...
(Date:2/8/2016)... , Feb. 8, 2016   GS1 US ... professionals to guide them through GS1 Standards implementation to ... Administration (FDA) Unique Device Identification (UDI) rule. ... US; Beth Gibson , senior director industry development, ... industry development director, GS1 US --> ...
Breaking Medicine Technology: